SGD vs LGND vs PRGO vs GREE vs JNJ

For growth investors, Ligand Pharmaceuticals Incorporated (LGND) is the stronger pick with 27.

3% revenue growth year-over-year, versus -15. 4% for Greenidge Generation Holdings Inc. (GREE). Johnson & Johnson (JNJ) offers the better valuation at 38. 2x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate Ligand Pharmaceuticals Incorporated (LGND) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Perrigo Company plc is actually cheaper at 5.

5x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Ligand Pharmaceuticals Incorporated (LGND) delivered a total return of +74.

8%, compared to -99. 9% for Safe and Green Development Corporation (SGD). Over 10 years, the gap is even starker: JNJ returned +131. 3% versus SGD's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Johnson & Johnson (JNJ) is the lower-risk stock at 0.

04β versus Greenidge Generation Holdings Inc. 's 3. 37β — meaning GREE is approximately 7396% more volatile than JNJ relative to the S&P 500. On balance sheet safety, Ligand Pharmaceuticals Incorporated (LGND) carries a lower debt/equity ratio of 1% versus 12% for Safe and Green Development Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Ligand Pharmaceuticals Incorporated (LGND) is pulling ahead at 27.

3% versus -15. 4% for Greenidge Generation Holdings Inc. (GREE). On earnings-per-share growth, the picture is similar: Greenidge Generation Holdings Inc. grew EPS 57. 6% year-over-year, compared to -21. 2% for Safe and Green Development Corporation. Over a 3-year CAGR, JNJ leads at 4. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Johnson & Johnson (JNJ) is the more profitable company, earning 15.

8% net margin versus -42. 9% for Safe and Green Development Corporation — meaning it keeps 15. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JNJ leads at 24. 9% versus -31. 6% for SGD. At the gross margin level — before operating expenses — LGND leads at 93. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

5x forward P/E versus 24. 6x for Ligand Pharmaceuticals Incorporated — 19. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 209. 1% to $36. 20.

In this comparison, PRGO (9.

8% yield), JNJ (2. 2% yield) pay a dividend. SGD, LGND, GREE do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Johnson & Johnson (JNJ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

04), 2. 2% yield, +131. 3% 10Y return). Greenidge Generation Holdings Inc. (GREE) carries a higher beta of 3. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JNJ: +131. 3%, GREE: -62. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SGD (Real Estate) and LGND (Healthcare) and PRGO (Healthcare) and GREE (Financial Services) and JNJ (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SGD is a small-cap quality compounder stock; LGND is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock; GREE is a small-cap quality compounder stock; JNJ is a large-cap quality compounder stock. PRGO, JNJ pay a dividend while SGD, LGND, GREE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.